Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 136
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00370981 | Exploratory Study of Pagoclone in Men With Premature Ejaculation. | ||
| NCT01483963 | AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder | ||
| NCT01515540 | Brain Imaging of Lidoderm for Chronic Back Pain | ||
| NCT00652093 | Lumbar Stenosis Outcomes Research II | ||
| NCT00904280 | Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy | ||
| NCT05152173 | Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis | ||
| NCT00954746 | Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859 | ||
| NCT01221597 | Study of AA4500 in the Treatment of Peyronie's Disease | ||
| NCT00904475 | Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain | ||
| NCT00426985 | Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis | ||
| NCT04607187 | Ultrasound B Mode Imaging and Elastography | ||
| NCT05254457 | Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis | ||
| NCT04496167 | Safety and Efficacy of EN3835 in Participants With Frozen Shoulder | ||
| NCT04209530 | Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women | ||
| NCT05877066 | Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture | ||
| NCT00904605 | Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee | ||
| NCT05777031 | Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease | ||
| NCT00884715 | Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome | ||
| NCT05026216 | To Assess the Effectiveness of Multiple Dose, Multiple Concentrations of Qwo, for the Treatment of Mild to Moderate Cellulite. | ||
| NCT01243411 | A Study of AA4500 in Men With Peyronie's Disease | ||
| NCT02687451 | Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects | ||
| NCT02006719 | Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder | ||
| NCT01407068 | Administration of Two Injections for Multiple Dupuytren's Contractures | ||
| NCT01316874 | Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) | ||
| NCT02267460 | An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease | ||
| NCT00638079 | Evaluating the Effect of Food on Absorption of Megace ES | ||
| NCT01606345 | Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma | ||
| NCT00913055 | Open Label Study of Octreotide Implant in Patients With Acromegaly | ||
| NCT04786106 | Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's | ||
| NCT01317641 | Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer | ||
| NCT00904449 | Open Label Assessment of Long-Term Safety and Utility | ||
| NCT03428750 | Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women | ||
| NCT03767452 | Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response | ||
| NCT04093050 | Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers | ||
| NCT01035983 | Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches | ||
| NCT01221623 | Study of AA4500 in the Treatment of Peyronie's Disease | ||
| NCT04681027 | Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children | ||
| NCT00801398 | Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects. | ||
| NCT01697384 | Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer | ||
| NCT00765856 | Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects | ||
| NCT01685437 | A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease | ||
| NCT00574860 | EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer | ||
| NCT05249257 | Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity | ||
| NCT01310803 | Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder | ||
| NCT00528424 | AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease | ||
| NCT04580303 | CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques | ||
| NCT03675685 | Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP | ||
| NCT05873595 | Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease | ||
| NCT00475514 | A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine | ||
| NCT03518034 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men |
